Replies to post #542 on Dendreon Corp fka DNDNQ

[poorgradstudent]

Sam,

Is DNDN the first stock you've followed that is being manipulated as such?

>I bow to your earful of a world leader in drug pipelines and his considered opinion.<

Not a world leader in drug pipelines, but a world leader in basic research into the TRP family. His lab has done the initial characterization for a lot of the variants.

[DewDiligence]

>I think that Roche is pulling the strings from afar, telling b: DNA to stop assisting (co-working small molecules) their future competiton, and a. hedge funds to keep DNDN on the griddle, looking like a failing company dependent on a one-trick pony. When I stop to take stock of where we are: Neuvenge is in the freezer (drop-kicked there by herceptin) and now the tainting of trp-p8 is being quietly debuted.<

You’re delusional, IMO.

[walldiver]

Sam, DNA and Roche have so many small biotech collaborators (numbering in the hundreds) that DNDN isn't even a pimple on their butt cheeks.